Managing Diabetic Patients With Moderate or Severe Renal Impairment Using DPP-4 Inhibitors: Focus on Vildagliptin

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - New Zealand

doi 10.2147/dmso.s28951